Search

everythinglearnresearchcommunity

for

Search:↓

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

TNF-alpha inhibitors can cause various immune-related skin issues.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Hodgkin's lymphoma can show up as hair loss.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Tislelizumab can cause cutaneous lupus erythematosus.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Removing the liver tumor improved the patient's skin condition and hair growth.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

The treatment was effective for lupus nephritis with manageable side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Dupilumab can both heal and cause hair loss.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

ILC1-like cells can independently cause alopecia areata.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Belimumab may cause hair loss in lupus patients.